Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Last Updated: February 7, 2023

Invatech Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for INVATECH, and what generic and branded alternatives to INVATECH drugs are available?

INVATECH has nine approved drugs.

Summary for Invatech

US Patents:	0
Tradenames:	8
Ingredients:	8
NDAs:	9

Drugs and US Patents for Invatech

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Invatech	GABAPENTIN	gabapentin	TABLET;ORAL	076877-002	Jul 6, 2006		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Invatech	BUPROPION HYDROCHLORIDE	bupropion hydrochloride	TABLET;ORAL	075613-002	Oct 10, 2000		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Invatech	PROMETHAZINE HYDROCHLORIDE	promethazine hydrochloride	TABLET;ORAL	085146-001	Approved Prior to Jan 1, 1982		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Invatech	PROMETHAZINE HYDROCHLORIDE	promethazine hydrochloride	TABLET;ORAL	084233-001	Approved Prior to Jan 1, 1982		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Invatech	DIVALPROEX SODIUM	divalproex sodium	TABLET, DELAYED RELEASE;ORAL	078290-002	Jul 29, 2008	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck

Dow

Moodys

Colorcon

McKinsey

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.